Author： Boltz David A. AldridgeJr Jerry R. Webster Robert G. Govorkova Elena A.
Publisher： Adis International
ISSN： 0012-6667
Source： Drugs, Vol.70, Iss.11, 2010-07, pp. : 1349-1362
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Preclinical Development of Low Toxicity Drugs: Focus on Zanamivir, an Anti-Influenza Drug
By Dines G.D.
Drug Safety, Vol. 19, Iss. 3, 1998-09 ,pp. :
Development of antivirals against influenza
Expert Opinion on Investigational Drugs, Vol. 7, Iss. 2, 1998-02 ,pp. :
Antiviral drugs for influenza: Tamiflu® past, present and future
By Laver Graeme
Future Virology, Vol. 1, Iss. 5, 2006-09 ,pp. :